Background The objective of this study was to review and describe the usage of fluorine-labeled deoxyglucose (FDG) and positron emission tomography (PET) in the diagnosis and management of head
Positron emission tomography scanning using a fluorine-labeled deoxyglucose (FDG) radiotracer proved as reliable as conventional scanning for primary and metastatic tumor identification. Compared with clinical examination, PET was better for identification of nodal metastatic tumors but …
Review Article Classification, Ontology, Gupta T, Master Z, Kannan S, et al. Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review
Diagnostic Performance of Post-treatment FDG PET or FDG PET/CT Imaging in Head and Neck Cancer: a Systematic Review and Meta-analysis Gupta T, Master Z, Kannan S, et al Eur J Nucl Med Mol Imaging
Review PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted Imaging Laura K.van Dijk1,2, Otto C. Boerman2, Johannes H.A.M. Kaanders1, and Johan Bussink1 Abstract
The prospective randomized controlled PET-NECK Trial was launched to determine the clinical usefulness and cost-effectiveness of planned neck dissection versus PET-CT–guided surveillance in patients with advanced squamous cell carcinoma of the head and neck.
Methods. We searched MEDLINE and Cochrane Library databases from 1996 to March 2012 for relevant English-language studies of PET or PET-CT used for surveillance in patients with lymphoma, colorectal cancer, or head and neck cancer.
(Detection of Known Primary Head and Neck Cancer) False Negative PET’s for HNC are usually due to very small tumors • Review Article by Schoder/Yeung • 11 studies, 300 patients. • PET scan detects distant metastases in head and neck CA as well: • Fleming, Laryngoscope, 2007: 15%
PET/CT is highly sensitive in staging of patients with squamous cancer of the head and neck. The sensitivity is limited by tumor size, and PET/CT cannot currently replace the information obtained from elective neck dissection in the assessment of cervical metastases.
Objectives. Positron emission tomography-computed tomography (PET/CT) with fluorine-18-fluorodeoxy-D-glucose (FDG) has evolved from a research modality to an invaluable tool in head and neck cancer imaging.